Hofseth Biocare ASA(HOFBF)
$0.120.00 (0.00%)
HOFBF
Hofseth Biocare ASA stock drug pipeline
$0.12
At close:0.00 (0.00%)
Hofseth Biocare ASA (HOFBF) Drug Pipeline
6 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Salmon Protein Hydrolysate | Healthy | Phase I | Completed | A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females | May 14, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Salmon Protein Hydrolysate | Phase I | Healthy | Completed | A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females | May 14, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Hofseth Biocare ASA (HOFBF) have in its pipeline
Hofseth Biocare ASA HOFBF is currently developing the following drugs: Salmon Protein Hydrolysate. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
